155 related articles for article (PubMed ID: 27831925)
1. Synthesis, in-vitro cytotoxicity of 1H-benzo[f]chromene derivatives and structure-activity relationships of the 1-aryl group and 9-position.
Mohamed HM; Fouda AM; Khattab ESAEH; Agrody AME; Afifi TH
Z Naturforsch C J Biosci; 2017 May; 72(5-6):161-171. PubMed ID: 27831925
[TBL] [Abstract][Full Text] [Related]
2. Design of New Benzo[h]chromene Derivatives: Antitumor Activities and Structure-Activity Relationships of the 2,3-Positions and Fused Rings at the 2,3-Positions.
Okasha RM; Alblewi FF; Afifi TH; Naqvi A; Fouda AM; Al-Dies AM; El-Agrody AM
Molecules; 2017 Mar; 22(3):. PubMed ID: 28335470
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of antitumor activity of 9-methoxy-1H-benzo[f]chromene derivatives.
Elgaafary M; Lehner J; Fouda AM; Hamed A; Ulrich J; Simmet T; Syrovets T; El-Agrody AM
Bioorg Chem; 2021 Nov; 116():105402. PubMed ID: 34670333
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative effect, cell cycle arrest and apoptosis generation of novel synthesized anticancer heterocyclic derivatives based 4H-benzo[h]chromene.
Alblewi FF; Okasha RM; Hritani ZM; Mohamed HM; El-Nassag MAA; Halawa AH; Mora A; Fouda AM; Assiri MA; Al-Dies AM; Afifi TH; El-Agrody AM
Bioorg Chem; 2019 Jun; 87():560-571. PubMed ID: 30928878
[TBL] [Abstract][Full Text] [Related]
5. Introducing novel potent anticancer agents of 1H-benzo[f]chromene scaffolds, targeting c-Src kinase enzyme with MDA-MB-231 cell line anti-invasion effect.
Ahmed HEA; El-Nassag MAA; Hassan AH; Okasha RM; Ihmaid S; Fouda AM; Afifi TH; Aljuhani A; El-Agrody AM
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1074-1088. PubMed ID: 29923425
[TBL] [Abstract][Full Text] [Related]
6. A New Family of Benzo[
Abd-El-Aziz AS; Alsaggaf A; Assirey E; Naqvi A; Okasha RM; Afifi TH; Hagar M
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802075
[TBL] [Abstract][Full Text] [Related]
7. A proficient microwave synthesis with structure elucidation and the exploitation of the biological behavior of the newly halogenated 3-amino-1H-benzo[f]chromene molecules, targeting dual inhibition of topoisomerase II and microtubules.
Fouda AM; Okasha RM; Alblewi FF; Mora A; Afifi TH; El-Agrody AM
Bioorg Chem; 2020 Jan; 95():103549. PubMed ID: 31887476
[TBL] [Abstract][Full Text] [Related]
8. Rational design and synthesis of 6-aryl-6H-benzo[c]chromenes as non-steroidal progesterone receptor antagonists for use against cancers.
Qin J; Qu S; Zhu K; Cheng Y; Pan G; Jing W; Liu X; Sun X; Liu L
Bioorg Med Chem; 2021 Feb; 32():116003. PubMed ID: 33461148
[TBL] [Abstract][Full Text] [Related]
9. New 2-Imino-2H-Chromene-3(N-aryl)carboxamides as Potential Cytotoxic Agents.
Gill RK; Kumari J; Bariwal J
Anticancer Agents Med Chem; 2017; 17(1):85-92. PubMed ID: 26961315
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of 3,4-dihydro-2H-benzo[h]chromene derivatives as potential NF-κB inhibitors.
Choi M; Hwang YS; Kumar AS; Jo H; Jeong Y; Oh Y; Lee J; Yun J; Kim Y; Han SB; Jung JK; Cho J; Lee H
Bioorg Med Chem Lett; 2014 Jun; 24(11):2404-7. PubMed ID: 24792464
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of novel chromene derivatives of expected antitumor activity.
Kandeel MM; Kamal AM; Abdelall EK; Elshemy HA
Eur J Med Chem; 2013 Jan; 59():183-93. PubMed ID: 23220647
[TBL] [Abstract][Full Text] [Related]
12. Design and Synthesis of Novel Heterocyclic-Based 4
Alblewi FF; Okasha RM; Eskandrani AA; Afifi TH; Mohamed HM; Halawa AH; Fouda AM; Al-Dies AM; Mora A; El-Agrody AM
Molecules; 2019 Mar; 24(6):. PubMed ID: 30889862
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of β-Enaminonitrile-Linked 8-Methoxy-1
Elgaafary M; Fouda AM; Mohamed HM; Hamed A; El-Mawgoud HKA; Jin L; Ulrich J; Simmet T; Syrovets T; El-Agrody AM
Front Chem; 2021; 9():759148. PubMed ID: 34881224
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in-vitro cytotoxicity of poly-functionalized 4-(2-arylthiazol-4-yl)-4H-chromenes.
Mahmoodi M; Aliabadi A; Emami S; Safavi M; Rajabalian S; Mohagheghi MA; Khoshzaban A; Samzadeh-Kermani A; Lamei N; Shafiee A; Foroumadi A
Arch Pharm (Weinheim); 2010 Jul; 343(7):411-6. PubMed ID: 20309872
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Evaluation of Cytotoxic Activity of Certain Benzo[h]chromene Derivatives.
Awad SM; Mohamed MS; Khodair MAE; El-Hameed RHA
Anticancer Agents Med Chem; 2021; 21(8):963-986. PubMed ID: 32981512
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, Molecular Docking Study and in vitro Anticancer Activity of Tetrazole Linked Benzochromene Derivatives.
Gorle S; Maddila S; Maddila SN; Naicker K; Singh M; Singh P; Jonnalagadda SB
Anticancer Agents Med Chem; 2017; 17(3):464-470. PubMed ID: 27357544
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and docking studies of phenylpicolinamide derivatives bearing 1H-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors.
Zhu W; Wang W; Xu S; Tang Q; Luo R; Wang M; Gong P; Zheng P
Bioorg Med Chem; 2016 Feb; 24(4):812-9. PubMed ID: 26810712
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, estrogen receptor binding affinity and molecular docking of pyrimidine-piperazine-chromene and -quinoline conjugates.
Parveen I; Ahmed N; Idrees D; Khan P; Hassan MI
Bioorg Med Chem Lett; 2017 Sep; 27(18):4493-4499. PubMed ID: 28797797
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel 1,2,3-triazole/isoxazole functionalized 2H-Chromene derivatives and their cytotoxic activity.
Ratnakar Reddy K; Sambasiva Rao P; Jitender Dev G; Poornachandra Y; Ganesh Kumar C; Shanthan Rao P; Narsaiah B
Bioorg Med Chem Lett; 2014 Apr; 24(7):1661-3. PubMed ID: 24641975
[TBL] [Abstract][Full Text] [Related]
20. 2-Amino-3-cyano-4-(5-arylisoxazol-3-yl)-4H-chromenes: synthesis and in vitro cytotoxic activity.
Akbarzadeh T; Rafinejad A; Mollaghasem JM; Safavi M; Fallah-Tafti A; Pordeli M; Ardestani SK; Shafiee A; Foroumadi A
Arch Pharm (Weinheim); 2012 May; 345(5):386-92. PubMed ID: 22266847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
